Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03387345 · ClinicalTrials.gov registry record · NA

Barley and Rice Mixture Effects on Blood Glucose

A NA study of Hunger and Blood Glucose, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT03387345: Completed NA study of Hunger and Blood Glucose, sponsored by Arizona State University.

NCT03387345 is a NA study of Hunger and Blood Glucose that has completed, run by Arizona State University. The registered enrollment target is 39 participants, below the 81-participant average among 7 other Hunger trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03387345, a NA study of Hunger and Blood Glucose, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research was to investigate 5 different formulations of whole grain barley and refined white rice against a control of white bread on post-prandial glycemic response, as well as self-reported hunger/satiety in a randomized cross-over trial.

Primary Outcome

Incremental area under the curve(iAUC) for plasma glucose concentrations were measured at 0, 15, 30, 45, 60, 90 and 120 min using the trapezoidal method to evaluate the glycemic response to each grain treatment.

Interventions

  • OTHER 100% steel cut barley
  • OTHER 100% barley flakes
  • OTHER 50/50 rice-barley mix
  • OTHER 80/20 rice-barley mix
  • OTHER 100% rice

Study Locations (1)

Arizona

  • Arizona Biomedical Collaborative - Phoenix

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2017-02-13
Est. Completion 2017-09-18
Phase NA
Arizona State University

187 total trials

What the finished NCT03387345 record still lists

NCT03387345 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 81-participant average among 7 other Hunger trials with a reported enrollment target (52% lower).

The record links to 3 conditions, with Hunger appearing as the primary indexed condition, and to 5 interventions - of which 100% steel cut barley is the first listed.

NCT03387345 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT03387345 about?

NCT03387345 is a clinical study titled "Barley and Rice Mixture Effects on Blood Glucose". The purpose of this research was to investigate 5 different formulations of whole grain barley and refined white rice against a control of white bread on post-prandial glycemic response, as well as self-reported hunger/satiety in a randomized cross-over trial.

What is the current status of trial NCT03387345?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-02-13. Estimated completion is 2017-09-18.

What conditions does trial NCT03387345 study?

This clinical trial studies the following conditions: Hunger, Blood Glucose, Dietary Fiber.

What interventions are being tested in trial NCT03387345?

The interventions under investigation include: 100% steel cut barley (OTHER), 100% barley flakes (OTHER), 50/50 rice-barley mix (OTHER), 80/20 rice-barley mix (OTHER), 100% rice (OTHER).

Who is sponsoring clinical trial NCT03387345?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03387345 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hunger

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03387345, the US trial registry maintained by the National Library of Medicine. NCT03387345 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.